Caution, this is an AI generated summary based on literature. This may have errors, see here for more.
Please share your feedback with us.
hsa-mir-142: Hsa-mir-142 is one of the 10 significantly differentially expressed miRNAs that were selected for validation using the RT-qPCR method. It is an upregulated miRNA with a relatively high fold-change (fold-change ≥4 or ≤-4) [PMC5865992]. In a study on head and neck squamous cell carcinoma (HNSC) patients, high plasma levels of hsa-mir-142 were reported as a HPV-independent prognostic marker for combined radio-chemotherapy [PMC7794682].
References:
- [PMC5865992]: This reference provides information on the selection and validation of differentially expressed miRNAs using the RT-qPCR method.
- [PMC7794682]: This reference discusses the association between high plasma levels of hsa-mir-142 and prognosis in HNSC patients undergoing combined radio-chemotherapy.
mRNA interactions
2 total
Genome locations
Gene Ontology annotations
Ancestor Chart
Loading ontology ancestors...
Failed to load QuickGO Ancestor chart
Sequence
Sequence features are shown above as colored rectangles.
Zoom in and click to view details, or
Reset